ID   UCDK9M4
AC   CVCL_0C80
DR   Wikidata; Q54989612
RX   PubMed=21722969;
RX   PubMed=22901430;
RX   PubMed=30188000;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: German Shorthaired Pointer; VBO=VBO_0200583.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
RX   PubMed=21722969; DOI=10.1016/j.vetimm.2011.05.018; PMCID=PMC4169883;
RA   Aina O.H., Maeda Y., Harrison M., Zwingenberger A.L., Walker N.J.,
RA   Lam K.S., Kent M.S.;
RT   "Canine malignant melanoma alpha-3 integrin binding peptides.";
RL   Vet. Immunol. Immunopathol. 143:11-19(2011).
//
RX   PubMed=22901430; DOI=10.1016/j.jcpa.2012.07.001; PMCID=PMC3535688;
RA   Chon E., Thompson V., Schmid S., Stein T.J.;
RT   "Activation of the canonical Wnt/beta-catenin signalling pathway is
RT   rare in canine malignant melanoma tissue and cell lines.";
RL   J. Comp. Pathol. 148:178-187(2013).
//
RX   PubMed=30188000; DOI=10.1111/vco.12429;
RA   Shin H., Nam A., Song K.-H., Lee K., Rebhun R.B., Seo K.-W.;
RT   "Anticancer effects of high-dose ascorbate on canine melanoma cell
RT   lines.";
RL   Vet. Comp. Oncol. 16:616-621(2018).
//